Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ABPI > SEC Filings for ABPI > Form 8-K on 23-Nov-2012All Recent SEC Filings

Show all filings for ACCENTIA BIOPHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro



Triggering Events That Accelerate or Increase a Direct Financial

Item 2.04. Triggering Events that Accelerate or Increase a Direct Financial Obligation.

On November 17, 2012, Accentia Biopharmaceuticals, Inc. (the "Company") failed to pay an aggregate of $14.1 million in principal amount that became due on such date under a class of non-interest bearing convertible debentures issued in November 2010. As a result of this default, a default rate of 18% will begin accruing under the debentures, and the holders of such debentures further have the right to an additional default payment equal to 30% of the outstanding balance due. As of the date of this Form 8-K, none of the holders of the debentures have taken any action to secure a judgment against the Company.

  Add ABPI to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ABPI - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.